Suppr超能文献

微小RNA-370通过靶向SMAD1信号通路影响肺癌细胞的生物学行为。

miR-370 impacts the biological behavior of lung cancer cells by targeting the SMAD1 signaling pathway.

作者信息

Tang Zhaohui, Jiang Yongjun, Ding Sijuan, Jiang Shaohui, Tang Ruoting, Luo Pengfei

机构信息

Department of Oncology, The Central Hospital of Yongzhou No. 396 Yiyun Road, Yongzhou 425000, Hunan, China.

出版信息

Am J Transl Res. 2022 Nov 15;14(11):8117-8128. eCollection 2022.

Abstract

BACKGROUND

MicroRNAs (miRNAs) have been identified to play a role in the development and progression of lung cancer (LC). As of now, the expression and function of miR-370 in LC are still under investigation. Accordingly, this study explores the role and mechanism of miR-370 in LC.

METHODS

MiR-370 mimics or inhibitors were used to transfect A549 and NCI-H460 cells to overexpress or inhibit miR-370. The colony formation test and Cell Counting Kit-8 were conducted to detect the cell proliferation activity, and transwell test and wound healing test were conducted to evaluate the cell invasion and migration activities. In addition, the downstream target genes of miR-370 in LC were verified by dual luciferase reporter assay and western blot.

RESULTS

Compared to normal tissues and cell lineslines, the miR-370 expression in LC tissues and cells was decreased greatly. Compared to the negative control group, the up-regulation of miR-370 greatly intensified the apoptosis of NCI-H460 cells and weakened the migration, proliferation, and invasion of the cells. However, compared to the inhibitor-negative control group, the downregulation of miR-370 caused the opposite results. Additionally, SMAD family member 1 (SMAD1) was identified as a direct target of miR-370 in LC and could be inhibited by miR-370. Its overexpression restored the impact of miR-370 mimics on LC cells.

CONCLUSION

With low expression in LC tissues and cell lineslines, miR-370 is a tumor suppressor that weakens the growth, invasion as well as migration of LC cells by inhibiting SMAD1 expression. Our results may provide novel insights for the biological treatment of LC.

摘要

背景

微小RNA(miRNA)已被证实参与肺癌(LC)的发生发展过程。目前,miR-370在肺癌中的表达及功能仍在研究中。因此,本研究旨在探讨miR-370在肺癌中的作用及机制。

方法

使用miR-370模拟物或抑制剂转染A549和NCI-H460细胞,以过表达或抑制miR-370。通过集落形成试验和细胞计数试剂盒-8检测细胞增殖活性,通过Transwell试验和伤口愈合试验评估细胞侵袭和迁移活性。此外,通过双荧光素酶报告基因检测和蛋白质印迹法验证miR-370在肺癌中的下游靶基因。

结果

与正常组织和细胞系相比,肺癌组织和细胞中miR-370的表达显著降低。与阴性对照组相比,miR-370的上调显著增强了NCI-H460细胞的凋亡,并减弱了细胞的迁移、增殖和侵袭能力。然而,与抑制剂阴性对照组相比,miR-370的下调则产生了相反的结果。此外,SMAD家族成员1(SMAD1)被确定为miR-370在肺癌中的直接靶标,且可被miR-370抑制。其过表达恢复了miR-370模拟物对肺癌细胞的影响。

结论

miR-370在肺癌组织和细胞系中低表达,是一种肿瘤抑制因子,通过抑制SMAD1表达减弱肺癌细胞的生长、侵袭和迁移能力。我们的研究结果可能为肺癌的生物治疗提供新的见解。

相似文献

2
Over-expression of miR-187 inhibited cell proliferation and metastasis of glioma via down-regulating SMAD1.
Eur Rev Med Pharmacol Sci. 2019 Dec;23(24):10908-10917. doi: 10.26355/eurrev_201912_19794.
5
[MiR-665 Promotes the Biological Behavior of Small Cell Lung Cancer by Targeting LLGL1].
Zhongguo Fei Ai Za Zhi. 2020 Apr 20;23(4):223-232. doi: 10.3779/j.issn.1009-3419.2020.104.03. Epub 2020 Mar 30.
6
microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN.
Oncol Rep. 2012 Apr;27(4):1019-26. doi: 10.3892/or.2012.1645. Epub 2012 Jan 19.
10
Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.
Mol Cell Biochem. 2021 Jun;476(6):2253-2267. doi: 10.1007/s11010-021-04083-8. Epub 2021 Feb 11.

引用本文的文献

本文引用的文献

1
MicroRNA-155 and antiviral immune responses.
Int Immunopharmacol. 2021 Dec;101(Pt A):108188. doi: 10.1016/j.intimp.2021.108188. Epub 2021 Oct 6.
2
miR-370-3p as a Novel Biomarker Promotes Breast Cancer Progression by Targeting FBLN5.
Stem Cells Int. 2021 Aug 23;2021:4649890. doi: 10.1155/2021/4649890. eCollection 2021.
3
Toward personalized treatment approaches for non-small-cell lung cancer.
Nat Med. 2021 Aug;27(8):1345-1356. doi: 10.1038/s41591-021-01450-2. Epub 2021 Aug 12.
4
Lung cancer.
Lancet. 2021 Aug 7;398(10299):535-554. doi: 10.1016/S0140-6736(21)00312-3. Epub 2021 Jul 21.
5
Reduced PHLPP Expression Leads to EGFR-TKI Resistance in Lung Cancer by Activating PI3K-AKT and MAPK-ERK Dual Signaling.
Front Oncol. 2021 Jun 8;11:665045. doi: 10.3389/fonc.2021.665045. eCollection 2021.
6
MiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosis.
Stem Cell Res Ther. 2021 Jun 5;12(1):325. doi: 10.1186/s13287-021-02394-7.
7
MicroRNA: A signature for cancer progression.
Biomed Pharmacother. 2021 Jun;138:111528. doi: 10.1016/j.biopha.2021.111528. Epub 2021 Mar 23.
8
Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM interaction to facilitate CRC metastasis.
Mol Ther. 2021 Jun 2;29(6):2088-2107. doi: 10.1016/j.ymthe.2021.02.006. Epub 2021 Feb 9.
9
HOXD13 suppresses prostate cancer metastasis and BMP4-induced epithelial-mesenchymal transition by inhibiting SMAD1.
Int J Cancer. 2021 Jun 15;148(12):3060-3070. doi: 10.1002/ijc.33494. Epub 2021 Mar 6.
10
The role of Smad signaling cascades in cardiac fibrosis.
Cell Signal. 2021 Jan;77:109826. doi: 10.1016/j.cellsig.2020.109826. Epub 2020 Nov 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验